eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds.
Exozymes stock last closed at $10.47, down 3.41% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Exozymes stock is currently +23.18% from its 52-week low of $8.50, and -56.36% from its 52-week high of $23.99.
At the moment, there are 8.37M EXOZ shares outstanding. The market cap of EXOZ is $87.61M. In the past 24 hours, 5418 EXOZ shares were traded.
You need an online brokerage account to access the NASDAQ market and buy EXOZ stock.
In our opinion, eToro is the best place to buy stocks. Here's why:
Get $10 towards your purchase of stock by creating an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've picked your brokerage, the next step is to fill out some personal information so you can invest in EXOZ today.
Now that you have finished signing up on the best stock app for beginners, you can securely and quickly fund your account:
Watch the tutorial below to see the process of depositing funds into your investment account.
Once you have chosen the best place to buy Exozymes stock, it's important to evaluate their stock before you invest, so you can wrap your head around the risk as well as the opportunity.
WallStreetZen was created to help everyday investors perform better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on EXOZ's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge EXOZ's intrinsic value.
Using relative valuations methods:
You can access more valuation research on EXOZ's stock here.
Last year, EXOZ revenue was $0.00. During the last two year, EXOZ's revenue has gone up by -100% per year. This was slower than the Biotechnology industry average of 44.31%.
Dive into EXOZ's earnings and revenue performance here.
In the past year, insiders at EXOZ have bought more shares than they have sold.
Michael Heltzen, Chief Executive Officer of EXOZ, was the latest EXOZ insider to buy. They bought $19,048.26 worth of EXOZ shares on Jan 17, 2025.
Dig into more about who owns EXOZ stock here.
No, Exozymes doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
You have two primary types of orders:
Press the Open Trade button and your broker will place your order.
If you require additional help buying stocks on eToro, click the how to video below:
Now that you own some EXOZ shares, you'll want to keep up with your new shares.
Make a watchlist to track the latest developments regarding your EXOZ stock.
To reiterate, here are the 6 steps for buying Exozymes stock:
If you need a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to watch your investment in Exozymes, add EXOZ to your watchlist below.